2.Methods DPI and nutritional indices such as serum albumin(Alb),transferrin (TF),pre albumin (pre Alb)and insulin like growth factor 1(IGF 1) weremeasured in 36 patients with moderate to severe CRF and 20 normal controls (N).
3.FF 16, the newly developed catalyst in Fushun Research Institute of Petroleum and Petrochemicals, is a highly active pre hydrotreating catalyst characterized by high dispersion of active metal, higher surface area, larger pore diameter and moderate bulk density.
4.Methods Utilizing the rabbit model of BCT to develop moderate to severe MC,the cTn T and ME contents pre trauma and 4, 8 h and 24 h after MC were determined.
5.FFA showed absence of leakage in one eye,minimal leakage in 10 eyes,moderate leakage in 5 eyes. The areas of leakage decreased significantly than those pre-PDT(P<0.05).
6.Methods Moderate and severe HIE infants were randomized to pre-treatment group(n=10) and treatment group of 3 h(n=10),8 h(n=8) and 24 h(n=7)after a single subcutaneous EPO administration with a dose of 500 U/kg.
